Cas:1253789-11-5 7-Methyl-1-propyl-1H-pyrido[2,3-d][1,3]oxazine-2,4-dione manufacturer & supplier

Chemical Name:7-Methyl-1-propyl-1H-pyrido[2,3-d][1,3]oxazine-2,4-dione

CAS.NO:1253789-11-5

Synonyms:7-Methyl-1-propyl-1H-pyrido[2,3-d][1,3]oxazine-2,4-dione

Molecular Formula:C₁₁H₁₂N₂O₃

Molecular Weight:220.22500

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:65.10000

Exact Mass:220.08500

LogP:1.06810

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 7-Methyl-1-propyl-1H-pyrido[2,3-d][1,3]oxazine-2,4-dione chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,7-Methyl-1-propyl-1H-pyrido[2,3-d][1,3]oxazine-2,4-dione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,7-Methyl-1-propyl-1H-pyrido[2,3-d][1,3]oxazine-2,4-dione Use and application,7-Methyl-1-propyl-1H-pyrido[2,3-d][1,3]oxazine-2,4-dione technical grade,usp/ep/jp grade.

Related News: The market for pharmaceutical intermediates is vast and is expected to usher in new growth. Compared with the pesticide intermediate business, the market space for pharmaceutical intermediates is larger and will be the focus of the company’s future development. 7-Methyl-1-propyl-1H-pyrido[2,3-d][1,3]oxazine-2,4-dione manufacturer It wasn’t known if this was due to racial differences in breast cancer-related genetic mutations, making it unclear whether race should help guide genetic testing. 7-Methyl-1-propyl-1H-pyrido[2,3-d][1,3]oxazine-2,4-dione supplier The market for pharmaceutical intermediates is vast and is expected to usher in new growth. Compared with the pesticide intermediate business, the market space for pharmaceutical intermediates is larger and will be the focus of the company’s future development. 7-Methyl-1-propyl-1H-pyrido[2,3-d][1,3]oxazine-2,4-dione vendor US citizens who have been to China in the last 14 days need to re-book to one of seven gateway airports: John F. Kennedy International Airport in New York, Los Angeles International Airport, Seattle, San Francisco International Airport, Chicago, Atlanta and Honolulu. 7-Methyl-1-propyl-1H-pyrido[2,3-d][1,3]oxazine-2,4-dione factory The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.